Company Announcements

Publication of Final Terms

Source: RNS
RNS Number : 0690H
Adecco Intl Financial Services B.V.
04 October 2024
 

Adecco International Financial Services B.V.

4 October 2024

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 4 October 2024 (the "Final Terms") relating to the issue of EUR 300,000,000 3.400 per cent. Notes due 8 October 2032 (the "Notes") by Adecco International Financial Services B.V. under the EUR 3,500,000,000 Euro Medium Term Note Programme of Adecco Group AG, Adecco International Financial Services B.V., and Adecco Financial Services (North America), LLC unconditionally and irrevocably guaranteed by Adecco Group AG.

The Final Terms in respect of the Notes, contain the final terms of the Notes and must be read in conjunction with the base prospectus dated 15 May 2024, as supplemented by the supplemental prospectus dated 25 September 2024 (the "Base Prospectus").

To view the Final Terms, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/0690H_1-2024-10-4.pdf

The Final Terms in respect of the Notes has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Sandrine Wait-Studer

M&A and Finance Lawyer

Telephone:     +41 75 443 9311                                       

Email:            sandrine.wait@adeccogroup.com; legal@adeccogroup.com

 

 

Adecco Group AG

Bellerivestrasse 30

CH-8008 Zürich

Switzerland

 

 

Adecco International Financial Services B.V.

Hogeweg 123

5301 LL Zaltbommel

The Netherlands

 

 

Adecco Financial Services (North America), LLC

1209 Orange St.

Wilmington

DE 19801

United States

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms in respect of the Notes (when read together with the information in the Base Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Base Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained therein.

In particular, the Final Terms in respect of the Notes and the Base Prospectus do not constitute an offer of securities for sale in the United States of America. This is not for distribution in the United States of America. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States of America or to U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States of America.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTQZLFBZBLLFBQ